New response thresholds for RA demonstrate improved correlation with ultrasound-detected synovitis and ability to refine ...

The impact of the TB resurgence and multidrug resistance on clinical practice will be explored at Clinical Excellence in ...

Using CDK4/6 inhibitors as first-line therapy in advanced breast cancer does not improve overall survival compared with ...

Two complementary genome-wide association studies provide new insights into how host genetics influence the human gut ...

Prof Colin Berry describes stress CMR-based myocardial blood flow endotyping for patients with chest pain and unobstructed coronary arteries.

ECCO’26 focused on holistic care for inflammatory bowel disease, with multiple presentations focusing on ustekinumab ...

A novel risk calculator integrating comorbidities and gut-derived biomarkers stratifies risk of rehospitalisation and death ...

The JAK inhibitor deuruxolitinib has been approved by the MHRA as a treatment option for adults with severe alopecia areata.

Early prophylactic hydrocortisone for extremely preterm infants may increase BPD-free survival without raising rates of complications.

Dr Jitesh Neupane discusses his hematoids model and opportunities to study childhood blood disorders and future stem cell therapies.

A PSA test in midlife could help to identify men at low risk of prostate cancer, supporting screening strategies and reducing overdiagnosis.

People living with vitiligo experience substantial levels of mood- and stress-related mental health disorders, according to a cohort study.